Last reviewed · How we verify

NCT04050137: Aps

Therapeutic Exercise to Treat Neuropathic Pain

Completed NA Last updated 16 December 2020
What this trial tests

NA trial testing Therapeutic Exercise in Gaucher Disease in 5 participants. Completed in 14 December 2020.

Timeline
2 May 2019
Primary endpoint
1 December 2020
14 December 2020

Quick facts

Lead sponsorUniversidad de Zaragoza
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment5
Start date2 May 2019
Primary completion1 December 2020
Estimated completion14 December 2020
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Zaragoza — full company profile →

Who can join

Adults 16 to 65, any sex, with Gaucher Disease or Fabry Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A quasi-experimental, prospective clinical trial with pre and post intervention measurements, whose porpuose is assess the efficacy of a therapeutic exercise protocol to treat neuropathic pain in Fabry Disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Left to themselves: Time to target chronic pain in childhood rare diseases.
    Sieberg CB, Lebel A, Silliman E, Holmes S, et al · · 2021 · cited 5× · PMID 33774086 · DOI 10.1016/j.neubiorev.2021.03.008

Verify or expand the search:

Other trials of Therapeutic Exercise

Trials testing the same drug.

Other recruiting trials for Gaucher Disease

Currently open trials in the same condition.

Other Universidad de Zaragoza trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04050137.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing